Identification of amino acids within the second alpha helical domain of the human immunodeficiency virus type 1 Vpu that are critical for preventing CD4 cell surface expression

Virology

Volumn 397, Issue 1, 2010, Pages 104-112

  Hill, M Sarah ^a   Ruiz, Autumn ^a   Schmitt, Kimberly ^a   Stephens, Edward B ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha helical domain; CD4 down modulation; HIV 1; Human immunodeficiency virus type 1; SHIV; Simian human immunodeficiency virus; Vpu

Indexed keywords

ALANINE; AMINO ACID DERIVATIVE; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; CD4 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; LEUCINE; MUTANT PROTEIN; VALINE; VPU PROTEIN;

ALPHA HELIX; AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT;

AMINO ACIDS; ARTIFICIAL GENE FUSION; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MEMBRANE PROTEINS; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; VIRAL REGULATORY AND ACCESSORY PROTEINS;

CITRUS MAXIMA; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 73949135618     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.10.048     Document Type: Article

References (31)

1. Binette J., Dubé M., Mercier J., Halawani D., Latterich M., and Cohen E.A. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 4 (2007) 75
2. Butticaz C., Michielin O., Wyniger J., Telenti A., and Rothenberger S. Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. J. Virol. 3 (2007) 1502-1505
3. Cohen E.A., Terwilliger E.F., Sodroski J.G., and Haseltine W.A. Identification of a protein encoded by the vpu gene of HIV-1. Nature 334 (1988) 532-534
4. Douglas J.L., Viswanathan K., McCarroll M.N., Gustin J.K., Früh K., and Moses A.V. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a β-TrCP-dependent mechanism. J. Virol. 83 16 (2009) 7931-7947
5. Dubé M., Roy B.B., Guiot-Guillain P., Mercier J., Binette J., Leung G., and Cohen E.A. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 83 (2009) 4574-4590
6. Estrabaud E., Le Rouzic E., Lopez-Vergès S., Morel M., Belaïdouni N., Benarous R., Transy C., Berlioz-Torrent C., and Margottin-Goguet F. Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles. PLoS Pathog. (2007) 27, 3(7)
7. Fujita K., Omura S., and Silver J. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J. Gen. Virol. 78 (1997) 619-625
8. cpz strains. Virology 335 (2005) 46-60
9. + T cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 isolate. Virology 371 (2008) 86-97
10. TM) that is less pathogenic for pig-tailed macaques. Virology 339 (2005) 56-69
11. KU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques. Virology 344 (2006) 541-559
12. Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K.I., and Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 1 (2002) 55-67
13. Maldarelli F., Chen M.Y., Willey R.L., and Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67 (1993) 5056-5061
14. Mangeat B., Gers-Huber G., Lehmann M., Zufferey M., Luban J., and Piguet V. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 5 (2009) e1000574
15. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., and Benarous R. A novel human WD protein, h-beta TrCP, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1 (1998) 565-574
16. McCormick-Davis C., Dalton S.B., Singh D.K., and Stephens E.B. Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates. AIDS Res. Hum. Retrovir. 16 (2000) 1089-1095
17. Mitchell, R.S., Katsura, C., Skasko, M.A., Fitzpatrick, K., Lau, D., Ruiz, A., Stephens, E.B., Margottin-Gouget, F., Bemarous, R., Guatelli, J.C., 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta TrCP and endolysosomal trafficking. PLoS Pathog. 5, e1000450.
18. Neil S.J., Zang T., and Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451 (2008) 425-430
19. Pacyniak E., Gomez M.L., Mulcahy E.R., Jackson M.J., Hout D.R., Wisdom B.J., and Stephens E.B. Identification of a region within the cytoplasmic domain of the subtype B Vpu protein of human immunodeficiency virus type 1 (HIV-1) that is responsible for retention in the Golgi complex and its absence in the Vpu protein from subtype C HIV-1. AIDS Res. Hum. Retrovir. 21 (2005) 379-394
20. Paul M., and Jabbar M.A. Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4. Virology 232 (1997) 207-216
21. Schubert U., Henklein P., Boldyreff B., Wingender E., Strebel K., and Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J. Mol. Biol. 236 (1994) 16-25
22. Schubert U., Bour S., Ferrer-Montiel A.V., Montal M., Maldarell F., and Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70 (1996) 809-819
23. Schubert U., Anton L.C., Bacik I., Cox J.H., Bour S., Bennink J.R., Orlowski M., Strebel K., and Yewdell J.W. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72 (1998) 2280-2288
24. Schwartz S., Felber B.K., Fenyö E.M., and Pavlakis G.N. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64 (1990) 5448-5456
25. KU-lbMC33 in pig-tailed macaques. Virology 313 (2003) 435-451
26. Strebel K., Klimkait T., and Martin M.A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241 (1988) 1221-1223
27. Tiganos E., Yao X.J., Friborg J., Daniel N., and Cohen E.A. Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule. J. Virol. 71 (1997) 4452-4460
28. Tiganos E., Friborg J., Allain B., Daniel N.G., Yao X.J., and Cohen E.A. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein. Virology 251 (1998) 96-107
29. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., and Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is down-regulated from the cell surface by the viral Vpu protein. Host Cell Microbe 3 (2008) 245-252
30. Younger J.M., Chen L., Ren H.Y., Rosser M.F., Turnbull E.L., Fan C.Y., Patterson C., and Cyr D.M. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126 (2006) 571-582
31. Willey R.L., Maldarelli F., Martin M.A., and Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66 (1992) 226-234